RNA polymerase variants

Engineered RNA polymerase variants address the challenges of low yield and fidelity by improving activity and thermostability, resulting in enhanced RNA production efficiency and reduced undesirable products, making them more effective for therapeutic and analytical uses.

WO2024238367A1PCT designated stage expired Publication Date: 2024-11-21CODEXIS INC
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
PCT/US2024/028884
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-05-12
Filing Date
2024-05-10
Publication Date
2024-11-21

AI Technical Summary

Technical Problem

Current RNA polymerases face challenges in producing RNA with high yield and fidelity, often resulting in undesirable products such as incomplete transcripts and double-stranded RNA, which limits their effectiveness in therapeutic and analytical applications.

Method used

Engineered RNA polymerase variants with specific amino acid sequences, exhibiting increased activity, thermostability, and improved co-capping capabilities, are developed to enhance RNA production efficiency and yield.

Benefits of technology

The engineered RNA polymerases demonstrate improved RNA production with increased yield and fidelity, reducing the formation of undesirable products and enhancing their suitability for therapeutic and analytical applications.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure IMGF000009_0001
    Figure IMGF000009_0001
  • Figure IMGF000027_0001
    Figure IMGF000027_0001
  • Figure IMGF000127_0001
    Figure IMGF000127_0001
Patent Text Reader

Abstract

The present disclosure relates to engineered RNA polymerase polypeptides and compositions thereof, as well as polynucleotides encoding the engineered RNA polymerase polypeptides. The present disclosure also provides methods of using the engineered RNA polymerase polypeptides or compositions thereof for producing RNA.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Polypeptides derived from rna polymerases and use thereof

    US20040091854A1

  • T7 RNA polymerase variants

    US20190002851A1

  • T7 RNA polymerase variants

    US20200354699A1

  • RNA polymerase variants for co-transcriptional capping

    WO2020172239A1